Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

The organization and consequences of eicosanoid signaling

Open access
Soberman, Roy J., Christmas, Peter · 2003 · Journal of Clinical Investigation

Abstract

Organization of leukotriene and prostaglandin synthesisAs described in the introduction to this Perspective series (1), signaling by arachidonic acid represents a paradigm for the use of oxygen in the transmission of information.At the same time, arachidonic acid signaling can also contribute to the propagation of cellular damage.This duality is typified by a signaling cascade that (a) prevents the activation of 5-lipoxygenase (5-LO) in resting cells and (b) results in the formation and release of leukotrienes (LTs), which requires the sequential activation and interaction of at least eight different proteins.In fact, all lipoxygenases require membrane translocation to exert activity.In the case of the formation of COX products, particularly prostaglandin E 2 (PGE 2 ) and PGD 2 , humans have evolved two sets of biosynthetic enzymes that differ not only in their cell-and tissue-specific localization, but also in their subcellular localization and requirement for reduced glutathione, a cellular defense against oxidative damage.This review will focus on three aspects of arachidonic acid biology.First, the compartmentalization and organization of eicosanoid synthesis, specifically LTs and PGs, will be discussed.This will illustrate the elaborate mechanisms that keep unwanted lipoxygenation at arm's length and also show that the enzymes such as glutathione-Stransferases, epoxide hydrolases, and carrier proteins that are commonly thought of as biosynthetic also belong to families that are generally considered to play a role in detoxification.Second, the potential cellular oxidative damage that is produced as a by-product of the use of oxygen and lipid substrates is examined.Finally, mechanisms that are used to amplify signaling diversity from a core of LTs and PGs are discussed. The role of leukotrienes C 4 and D 4 in diseaseLTs are the products of the 5-LO pathway of arachidonic acid metabolism (Figure 1).The initial interest in LTs followed largely from their association with the pathogenesis of asthma (2).LTC 4 , identified as the parent molecule of the sulfidopeptide LTs, is generated from eosinophils and mast cells in large amounts, and also from monocytes and macrophages (2-7).However, it is not formed by polymorphonuclear leukocytes (2-5).When released from cells, LTC 4 is converted to LTD 4 (2-7), and both exert their biological effects via G protein-coupled receptors (8, 9).LTD 4 and LTC 4 cause the constriction of smooth muscle, and the clinical correlate is bronchial smooth muscle constriction in asthma (2, 10, 11).The role of LTD 4 as a major contributor to asthmatic bronchospasm has been firmly established, and aerosolized LTD 4 and LTC 4 cause bronchospasm when taken by inhaler (10, 11).The metabolic product of LTD 4 , 5(S)-hydroxy,6(R)-cysteinyl-7,9,11-trans,14-cis-eicosatetraenoic acid, (LTE 4 ), has been found at high levels in the serum and urine of patients with asthma and allergic rhinitis (12).When cold-induced bronchoconstriction, allergen-induced asthma, and exercise-induced asthma were analyzed, antagonists of the 5-LO pathway were able to alleviate bronchospasm (13-17).Pretreatment with the LTD 4 receptor antagonist MK-0476 has been shown to block the bronchoconstrictive response to all forms of challenge and alleviate ongoing brochoconstriction (16).The use of LTD 4 receptor and 5-LO antagonists has also blocked the severity and occurrence of asthmatic attacks in clinical trials, and these agents are particularly effective in chronic mild asthma, for which they are recommended for clinical use (18-23).LTs are also considered to be central to the pathogenesis of allergic rhinitis, in which cells expressing the cysteinyl LT1 receptor are highly expressed in CD45 + nasal leukocytes, and recent studies have shown that cysteinyl LTs regulate the trafficking of T cells in vivo (24,25).Subsequently, LTD 4 receptor antagonists have proved to constitute an effective therapeutic modality for this disorder.Knockout animals that lack LTC 4 synthase have markedly attenuated vascular responses that are dependent on IgE-mediated LTC 4 release (26).As described above, LTD 4 and LTC 4 have been shown to function via both high-and low-affinity G protein-coupled receptors (8, 9, 27, 28), and these receptors are present on human eosinophils and monocytes,

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci18338

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 162

Metadata

Authors
Soberman, R. J., & Christmas, P.
Venue
Journal of Clinical Investigation
Published
2003-04-15
Volume
111
Issue
8
Pages
1107-1113
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1980461268
Cited by
162
References
7
FWCI
7.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The organization and consequences of eicosanoid signaling. https://app.cochat.ai/papers/10.1172/jci18338
The paper
Soberman, R. J., & Christmas, P. (2003). The organization and consequences of eicosanoid signaling. Journal of Clinical Investigation. https://doi.org/10.1172/jci18338

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.